01 42GlaxoSmithKline Inc.
02 2Merck Canada Inc.
01 31340589
02 22033044
03 62059263
04 22068790
05 52070230
06 22100269
07 22105487
08 82216634
09 22286126
10 32289753
11 22311988
12 22606282
13 12794377
14 12967453
15 23003988
16 13006192
01 6Abacavir Sulfate | Lamivudine
02 7Abacavir Sulfate | Lamivudine | Zidovudine
03 6DOLUTEGRAVIR SODIUM | ABACAVIR SULFATE | LAMIVUDINE
04 2DOLUTEGRAVIR SODIUM | LAMIVUDINE
05 2DORAVIRINE | LAMIVUDINE | TENOFOVIR DISOPROXIL FUMARATE
06 15Lamivudine
07 6Lamivudine | Zidovudine
01 6Oral Solution
02 10TABLET
03 28Tablet
01 22010-12-21
02 62011-05-02
03 22012-01-03
04 22012-03-05
05 22012-05-15
06 72012-06-02
07 82016-03-28
08 32016-06-08
09 22018-03-20
10 32018-05-14
11 22026-04-28
12 32031-01-24
13 12031-03-28
14 12036-11-29
Patent Expiration Date : 2011-05-02
Date Granted : 2001-04-10
Brand Name : COMBIVIR
Patent Number : 2059263
Filing Date : 1991-05-02
Strength per Unit : 150mg Lamivudine & 300mg Zidovudine
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-05-02
Date Granted : 2001-04-10
Patent Expiration Date : 2012-06-02
Date Granted : 2005-11-15
Brand Name : COMBIVIR
Patent Number : 2311988
Filing Date : 1992-06-02
Strength per Unit : 150mg Lamivudine & 300mg Zidovudine
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-06-02
Date Granted : 2005-11-15
Patent Expiration Date : 2012-03-05
Date Granted : 2002-09-24
Brand Name : COMBIVIR
Patent Number : 2105487
Filing Date : 1992-03-05
Strength per Unit : 150mg Lamivudine & 300mg Zidovudine
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-03-05
Date Granted : 2002-09-24
Patent Expiration Date : 2012-05-15
Date Granted : 2005-06-07
Brand Name : COMBIVIR
Patent Number : 2068790
Filing Date : 1992-05-15
Strength per Unit : 150mg Lamivudine & 300mg Zidovudine
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-05-15
Date Granted : 2005-06-07
Patent Expiration Date : 2011-05-02
Date Granted : 2001-04-10
Brand Name : 3TC
Patent Number : 2059263
Filing Date : 1991-05-02
Strength per Unit : 10mg / ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-05-02
Date Granted : 2001-04-10
Patent Expiration Date : 2018-03-20
Date Granted : 2003-08-12
Brand Name : 3TC
Patent Number : 2286126
Filing Date : 1998-03-20
Strength per Unit : 10mg / ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2003-08-12
Patent Expiration Date : 2016-03-28
Date Granted : 2004-07-20
Brand Name : 3TC
Patent Number : 2216634
Filing Date : 1996-03-28
Strength per Unit : 10mg / ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-03-28
Date Granted : 2004-07-20
Patent Expiration Date : 2011-05-02
Date Granted : 2001-04-10
Brand Name : 3TC
Patent Number : 2059263
Filing Date : 1991-05-02
Strength per Unit : 150mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-05-02
Date Granted : 2001-04-10
Patent Expiration Date : 2016-03-28
Date Granted : 2004-07-20
Brand Name : 3TC
Patent Number : 2216634
Filing Date : 1996-03-28
Strength per Unit : 150mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-03-28
Date Granted : 2004-07-20
Patent Expiration Date : 2012-01-03
Date Granted : 1999-02-23
Brand Name : HEPTOVIR
Patent Number : 2100269
Filing Date : 1992-01-03
Strength per Unit : 100mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-01-03
Date Granted : 1999-02-23
